STAT3β Enhances Sensitivity to Concurrent Chemoradiotherapy by Inducing Cellular Necroptosis in Esophageal Squamous Cell Carcinoma

SIMPLE SUMMARY: The prognosis of esophageal squamous cell carcinoma (ESCC) patients is poor, with a five-year survival of 15–34%. We examined the expression of STAT3α and STAT3β in pretreatment tumor biopsies of 105 ESCC patients who received concurrent chemoradiotherapy (CCRT) by immunohistochemist...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Zhen-Yuan, Yang, Ping-Lian, Luo, Wei, Yu, Shuai-Xia, Xu, Hong-Yao, Huang, Ying, Li, Rong-Yao, Chen, Yang, Xu, Xiu-E, Liao, Lian-Di, Wang, Shao-Hong, Huang, He-Cheng, Li, En-Min, Xu, Li-Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926856/
https://www.ncbi.nlm.nih.gov/pubmed/33670049
http://dx.doi.org/10.3390/cancers13040901

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926856/
https://www.ncbi.nlm.nih.gov/pubmed/33670049
http://dx.doi.org/10.3390/cancers13040901

Ejemplares similares